Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors.
about
A physiological role of the adenosine A3 receptor: sustained cardioprotectionInteractions of flavones and other phytochemicals with adenosine receptorsTargeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioningAdenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NOAllosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivativesNeoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosidesConstitutive activation of A(3) adenosine receptors by site-directed mutagenesisStructure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonistsCardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptorPyran Template Approach to the Design of Novel A3 Adenosine Receptor AntagonistsTargeted deletion of A(3) adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium.Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor.A novel cardioprotective function of adenosine A1 and A3 receptors during prolonged simulated ischemia.Protection of cardiac myocytes via delta(1)-opioid receptors, protein kinase C, and mitochondrial K(ATP) channels.Therapeutic receptor targets of ischemic preconditioning.Adenosine A3 receptors: novel ligands and paradoxical effects.2-Substituted adenosine derivatives: affinity and efficacy at four subtypes of human adenosine receptors.Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.Functionalized congeners of 1,4-dihydropyridines as antagonist molecular probes for A3 adenosine receptorsRole of adenosine A1 and A3 receptors in regulation of cardiomyocyte homeostasis after mitochondrial respiratory chain injury.Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists.Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury.A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists.Activation and Desensitization of Rat A3-Adenosine Receptors by Selective Adenosine Derivatives and Xanthine-7-Ribosides.p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.Adenosine receptors and reperfusion injury of the heartOverexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic heartsDistinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D.Cardioprotective effects of adenosine A1 and A3 receptor activation during hypoxia in isolated rat cardiac myocytes.A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogsAdenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists.Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotectionCharacterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes.Cytochrome P-450-catalyzed reactive oxygen species production mediates the (-)schisandrin B-induced glutathione and heat shock responses in H9c2 cardiomyocytes.Cardiac effects of adenosine in A(2A) receptor knockout hearts: uncovering A(2B) receptors.Cardioprotective action of CRF peptide urocortin against simulated ischemia in adult rat cardiomyocytes.Negative inotropic drugs alter indexes of cytosolic [Ca(2+)]-left ventricular pressure relationships after ischemia.Receptors subtypes involved in adenosine-mediated modulation of norepinephrine release from cardiac nerve terminals.The A2a/A2b receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium.
P2860
Q24650457-7864C557-925C-490B-8BE9-C33506137D54Q28207053-EDFD26F8-4F69-46BF-984D-524FF50099C9Q28361499-14312281-C7EF-4C55-AD7A-EDFE7EC1F0D5Q28362050-08D7156E-4193-4573-B95B-F0D3814EA358Q28362220-2838FA02-045D-421C-B67A-7C0A490045A8Q28364092-EF9A4F82-D4AC-4695-9A68-598931C56DD5Q28366534-6DE9FC5C-2F50-4238-8AD9-37513B90DB78Q28368377-623643C4-60A5-4789-B394-BAC2F0ADFAE1Q28771714-F41A891C-2C13-43BC-948D-EF7F2463A896Q28834245-5710E43E-2456-4047-B95B-464388741D90Q30307910-33DA0616-CE5C-4674-84D8-74AD845D16EFQ30453517-2ABA1BC4-A33D-4CF8-8899-584E8A8BD13DQ33797566-FEBFE36D-0466-4B2A-9C59-E0B23E37D968Q33928624-30C21E99-4B9A-41FC-B4AB-72EEEB129E9AQ34772406-0840A07A-0025-41E6-9101-0F639F7276B3Q35171034-03209DB8-3714-4DA4-BED2-CD77243571B3Q36128547-4DDC39A3-9836-41A3-B035-53CFF1DE16B5Q36146803-96686A14-E229-4E8D-82F0-675B9E668114Q36246984-400B4394-CC19-4DB8-B37B-3773F5F2E580Q36275939-42C772CB-5538-4C39-ABF8-D78907010CF9Q36316851-8A71F2B4-541B-4C4E-9976-1256E1BD50F9Q36473769-E316C7E8-E1B5-439C-9177-5EDBC4949AF3Q36580219-8F870659-FCE8-4711-B82A-A11BF8518CECQ36661011-82C52B64-9A7C-4E9B-97ED-7250CFCFB0D9Q36738027-ABC4BF9D-5A92-428F-8793-29FB5619F744Q37565166-5331D165-F2DB-476C-B94F-ED130C8A2FB6Q37602906-5D9E0CAD-170B-45FD-B020-D12E9BCAADF1Q41493835-FE4DEC1F-BB3D-4EEA-B8C4-0B91CA284FE1Q41541156-04A6EBA2-EAC9-4F66-80BF-FA01EA77298FQ41772465-3FF883B0-B30A-4BA9-9AA7-4DA87B307CC0Q41818308-8EC86947-5EE1-4DA6-8526-DFA12F055967Q41827778-A33F780E-BAA7-43CB-9402-AFA9BD5B8536Q42262261-3D71CEC4-F86D-48A9-B350-4275E7CD829AQ42545424-FFE40E74-06EE-4FB6-AC7E-15818C62905EQ43852650-C75C918B-9ED2-4FE0-BC12-38AC4A87ED5AQ44185555-907625EF-BBC7-43AE-B871-BECAA2B756EBQ44826857-8AC74917-FF25-4F28-9E8A-EA47279870F5Q45220367-0AEFA2E3-F1E3-4F77-9592-7D754E98B33AQ48419291-FEF78A39-08B0-4D65-9581-8F558083D5EB
P2860
Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Direct preconditioning of cult ...... denosine A2a and A3 receptors.
@en
Direct preconditioning of cult ...... denosine A2a and A3 receptors.
@nl
type
label
Direct preconditioning of cult ...... denosine A2a and A3 receptors.
@en
Direct preconditioning of cult ...... denosine A2a and A3 receptors.
@nl
prefLabel
Direct preconditioning of cult ...... denosine A2a and A3 receptors.
@en
Direct preconditioning of cult ...... denosine A2a and A3 receptors.
@nl
P2093
P2860
P356
P1476
Direct preconditioning of cult ...... denosine A2a and A3 receptors.
@en
P2093
J Strickler
K A Jacobson
P2860
P304
P356
10.1172/JCI118976
P407
P577
1996-10-01T00:00:00Z